Literature DB >> 22001099

Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.

Christian Moro1, Jumpei Uchiyama, Russ Chess-Williams.   

Abstract

OBJECTIVE: To investigate the effects of tissue stretch and muscarinic receptor stimulation on the spontaneous activity of the urothelium/lamina propria and identify the specific receptor subtype mediating these responses.
METHODS: Isolated strips of porcine urothelium with lamina propria were set up for in vitro recording of contractile activity. Muscarinic receptor subtype-selective antagonists were used to identify the receptors influencing the contractile rate responses to stretch and stimulation with carbachol.
RESULTS: Isolated strips of urothelium with lamina propria developed spontaneous contractions (3.7 cycles/min) that were unaffected by tetrodotoxin, Nω-nitro-L-arginine, or indomethacin. Carbachol (1 μM) increased the spontaneous contractile rate of these tissue strips by 122% ± 27% (P < .001). These responses were significantly depressed in the presence of the M3-selective muscarinic antagonist 4-diphenylacetoxy-N-methylpiperidine methiodide (10-30 nM) but were not affected by the M1-selective antagonist pirenzepine (30-100 nM) or the M2-selective antagonist methoctramine (0.1-1 μM). Stretching of the tissue also caused an increase in the spontaneous contractile rate, and these responses were abolished by atropine (1 μM) and low concentrations of 4-diphenylacetoxy-N-methylpiperidine methiodide (10 nM). Darifenacin, oxybutynin, tolterodine, and solifenacin (1 μM) all significantly depressed the frequency responses to carbachol (1 μM).
CONCLUSION: The urothelium with the lamina propria exhibits a spontaneous contractile activity that is increased during stretch. The mechanism appears to involve endogenous acetylcholine release acting on M3 muscarinic receptors. Anticholinergic drugs used clinically depress the responses of these tissues, and this mechanism might represent an additional site of action for these drugs in the treatment of bladder overactivity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001099     DOI: 10.1016/j.urology.2011.08.039

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

Review 1.  β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Authors:  Yasuhiko Igawa; Naoki Aizawa; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-05-03       Impact factor: 8.739

Review 2.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

3.  Enhanced urothelial ATP release and contraction following intravesical treatment with the cytotoxic drug, doxorubicin.

Authors:  Sung-Hyun Kang; Catherine McDermott; Stefanie Farr; Russ Chess-Williams
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-17       Impact factor: 3.000

4.  Comparative functional selectivity of imidafenacin and propiverine, antimuscarinic agents, for the urinary bladder over colon in conscious rats.

Authors:  Yukiko Muraki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-28       Impact factor: 3.000

5.  The Dependence of Urinary Bladder Responses on Extracellular Calcium Varies Between Muscarinic, Histamine, 5-HT (Serotonin), Neurokinin, Prostaglandin, and Angiotensin Receptor Activation.

Authors:  Charlotte Phelps; Russ Chess-Williams; Christian Moro
Journal:  Front Physiol       Date:  2022-03-31       Impact factor: 4.566

6.  The actions of neurotensin in rat bladder detrusor contractility.

Authors:  Xingyou Dong; Xinyu Bai; Jiang Zhao; Liang Wang; Qingqing Wang; Longkun Li
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

7.  Phasic contractions in urinary bladder from juvenile versus adult pigs.

Authors:  Bahareh Vahabi; Donna J Sellers; Dominika A Bijos; Marcus J Drake
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

8.  Luminal DMSO: effects on detrusor and urothelial/lamina propria function.

Authors:  Katrina J Smith; Russ Chess-Williams; Catherine McDermott
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

Review 9.  Signalling molecules in the urothelium.

Authors:  Michael Winder; Gunnar Tobin; Daša Zupančič; Rok Romih
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

10.  Purinergic and muscarinic modulation of ATP release from the urothelium and its paracrine actions.

Authors:  Guiping Sui; Chris H Fry; Bruce Montgomery; Max Roberts; Rui Wu; Changhao Wu
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.